South African HIV ART Guidelines Flashcards (92 cards)

All cards

1Question

What is the principal goal of ART?

Answer

To attain and maintain viral suppression.

2Question

What does viral suppression through ART help prevent?

Answer

New HIV infections.

3Question

How does ART affect life expectancy?

Answer

It increases life expectancy.

4Question

How does ART affect morbidity and mortality?

Answer

It decreases morbidity and mortality.

5Question

Who is eligible for ART regardless of age, CD4 count, or clinical stage?

Answer

All people living with HIV.

6Question

When should ART start if there are no contraindications?

Answer

Within 7 days, or on the same day if possible.

7Question

What should be investigated before ART in clients with cough, night sweats, fever, or recent weight loss?

Answer

Tuberculosis.

8Question

When should ART start for non-neurological drug-sensitive TB with CD4 below 50 cells/µL?

Answer

Within 2 weeks of TB treatment, once symptoms improve and treatment is tolerated.

9Question

When should baseline investigations be performed before ART?

Answer

Before ART; results need not be available for same-day initiation if there is no clinical evidence of TB, meningitis, or renal disease.

10Question

For ages 10 to under 16 years, what formula calculates eGFR?

Answer

height in cm×40serum creatinine in µmol/L\frac{\text{height in cm} \times 40}{\text{serum creatinine in µmol/L}}

11Question

For adults and adolescents aged at least 16, what MDRD eGFR permits TDF use?

Answer

Above 50 mL/min/1.73 m².

12Question

Which HIV-positive infants should receive cotrimoxazole preventive therapy?

Answer

All infants under 1 year, regardless of CD4 percentage or clinical stage.

13Question

What must be ruled out before starting TB preventive therapy?

Answer

Active TB must be ruled out clinically and by testing.

14Question

What is the TB preventive therapy regimen for non-pregnant adults or adolescents aged 15 or older?

Answer

Isoniazid 300 mg daily for 12 months with pyridoxine 25 mg daily.

15Question

What is the isoniazid regimen for children under 15 with HIV, including neonates with significant TB exposure?

Answer

Isoniazid 10 mg/kg/day for 6 months, capped at 300 mg daily, plus daily pyridoxine.

16Question

What class of antiretroviral is dolutegravir?

Answer

An integrase inhibitor.

17Question

What is the adult TLD combination’s minimum age and weight?

Answer

10 years and 30 kg.

18Question

How should DTG dosing change with rifampicin-containing TB treatment?

Answer

Increase DTG to 50 mg every 12 hours.

19Question

What does TLD1 indicate about a client's treatment history?

Answer

The client has never failed a previous regimen.

20Question

What does TLD2 indicate about a client's treatment history?

Answer

The client has failed an earlier regimen.

21Question

When should family planning and contraception be discussed during clinical care?

Answer

At every clinical interaction.

22Question

How should contraceptive options be offered during family planning discussions?

Answer

Through integrated, patient-centred services and informed voluntary choice.

23Question

Which TB treatment drug interacts with all paediatric ART regimens?

Answer

Rifampicin.

24Question

What LPV/r tablet dose should clients who can swallow whole tablets receive with rifampicin?

Answer

Double the standard dose.

25Question

What should be added twice daily for clients using LPV/r solution with rifampicin?

Answer

Ritonavir powder.

26Question

What ART should children and adolescents not yet on ART start when TB treatment begins?

Answer

A dolutegravir-containing regimen, with dolutegravir boosting as indicated.

27Question

What ART options are recommended for adults not yet on ART when TB treatment begins?

Answer

A boosted dolutegravir-containing regimen, or an efavirenz-containing regimen if ART-treatment-naive.

28Question

What should clients taking dolutegravir when TB treatment begins do?

Answer

Continue their regimen, with dolutegravir boosting as indicated.

29Question

How long should virally suppressed clients continue efavirenz after TB treatment ends?

Answer

Two weeks, then efavirenz can be switched to dolutegravir.

30Question

How many sessions does enhanced adherence counselling have, and who receives the second?

Answer

It has two sessions; the second is for persistently non-adherent patients.

31Question

What should clinicians do during an initial enhanced adherence counselling session?

Answer

Explain its purpose, explore reasons for abnormal results and adherence barriers, discuss strategies, and make or update an adherence plan with the patient.

32Question

Which areas does basic mental-health screening assess?

Answer

Appearance, mood, thoughts, and cognition.

33Question

What symptoms can suggest depression versus psychosis?

Answer

Negative thoughts can suggest depression; unusual thoughts or experiences can suggest psychosis.

34Question

Which situations indicate direct referral for psychiatric support?

Answer

Intense sadness, risk of harm to self or others, or hearing or seeing things others do not.

35Question

What should be done after an abacavir hypersensitivity reaction?

Answer

Stop abacavir permanently.

36Question

When should zidovudine be avoided or used cautiously in children?

Answer

In neonates or children with haemoglobin below 8 g/dL.

37Question

What is the minimum age and weight for adolescent tenofovir prescribing?

Answer

At least 10 years old and 35 kg.

38Question

What film-coated dolutegravir dose corresponds to 30 mg dispersible tablets?

Answer

50 mg.

39Question

At what ages should full HIV-status disclosure ideally occur for a mature child with normal cognition?

Answer

Between ages 10 and 14, before sexual debut.

40Question

How should HIV-status disclosure progress over time for a child?

Answer

Gradually from partial disclosure to full disclosure, followed by ongoing support.

41Question

Which concerns should healthcare professionals and consumers report to SAHPRA’s pharmacovigilance office?

Answer

All adverse drug reactions, adverse events following immunisation, and product-quality concerns.

42Question

Which groups should be prioritised for rapid ART initiation?

Answer

Pregnant women, infants, children under 5, and clients with advanced HIV disease.

43Question

When should pregnant or breastfeeding women with non-neurological TB start ART?

Answer

Within 2 weeks of TB treatment, once symptoms improve and treatment is tolerated.

44Question

When should ART start for drug-resistant TB at a non-neurological site?

Answer

After 2 weeks of TB treatment, once symptoms improve and treatment is tolerated.

45Question

How long should ART be deferred for neurological-site TB?

Answer

Until 4–8 weeks after TB treatment starts.

46Question

When may an asymptomatic client with positive serum cryptococcal antigen and negative lumbar puncture start ART?

Answer

Immediately, with no ART delay.

47Question

How long should ART be deferred for confirmed cryptococcal meningitis?

Answer

Until 4–6 weeks of antifungal treatment have been completed.

48Question

What counselling should paediatric clients and their caregivers receive?

Answer

Counselling on medication administration, side-effect monitoring, and adherence challenges.

49Question

What areas does baseline evaluation cover before ART?

Answer

History and examination, danger signs, nutrition, TB and meningitis, mental health and substance use, chronic diseases, pregnancy and fertility intentions, STIs, child neurodevelopment, and WHO clinical stage.

50Question

What MUAC threshold requires nutritional support or referral for women?

Answer

Below 23 cm.

51Question

What TB screening is done at HIV care enrolment and first antenatal visits?

Answer

Symptom screening, clinical examination, and routine MTB/Rif Ultra testing at enrolment; pregnant women receive these at their first antenatal visit.

52Question

What additional TB tests are recommended for symptomatic hospitalized people with HIV?

Answer

Urine LAM, chest X-ray if clinically indicated, and investigations for extrapulmonary TB if clinically indicated, in addition to MTB/Rif Ultra testing.

53Question

For pregnant women, what serum creatinine level permits TDF use?

Answer

Below 85 µmol/L.

54Question

How can dolutegravir affect serum creatinine early in treatment?

Answer

It may cause a rise of less than 15% by reducing tubular secretion without affecting glomerular filtration.

55Question

When should HIV-positive children aged 1–5 years start cotrimoxazole?

Answer

When CD4 is at most 25% or WHO stage is 2, 3, or 4.

56Question

When should HIV-positive people older than five start cotrimoxazole?

Answer

When CD4 is at most 200 cells/µL or WHO stage is 2, 3, or 4.

57Question

Must a tuberculin skin test be done before TB preventive therapy?

Answer

No tuberculin skin test is required.

58Question

What testing is required before TB preventive therapy for well children without TB symptoms?

Answer

Neither sputum testing nor a chest X-ray is required.

59Question

What should a well child unable to expectorate do if testing is unavailable?

Answer

Start TB preventive therapy even if chest X-ray or sputum testing is unavailable.

60Question

Which clients may use weekly isoniazid and rifapentine for 3 months?

Answer

Eligible clients on DTG with viral load below 50 copies/mL in the previous 6 months at selected locations.

61Question

What is the minimum weight for paediatric ALD?

Answer

25 kg.

62Question

From what age and weight are dolutegravir 10 mg dispersible tablets available?

Answer

From 4 weeks of age and 3 kg.

63Question

What is the standard daily DTG dose for children weighing at least 20 kg, adults, and adolescents?

Answer

50 mg daily.

64Question

When may calcium or iron supplements be taken with DTG at the same time?

Answer

When taken with food.

65Question

Which ART lines may use TLD?

Answer

First-line, second-line, and, with other medicines in certain cases, third-line ART.

66Question

Which ART clients should be evaluated for a switch to a DTG-containing regimen?

Answer

All clients not taking DTG, including those on first- or second-line treatment.

67Question

What regimen should clients returning after more than 90 days restart after prior TDF, TLD, or protease-inhibitor treatment?

Answer

A DTG-containing regimen.

68Question

Which contraceptive options are available?

Answer

Condoms, oral contraceptives, implants, injectables, and intrauterine contraceptive devices.

69Question

What does dual contraception use to prevent pregnancy and STIs or HIV?

Answer

A hormonal method or intrauterine device with a male or female condom.

70Question

What should a woman establish before trying to conceive while receiving ART?

Answer

She should establish ART, attain viral suppression, and have no current opportunistic infections.

71Question

Which ART combinations must not be given with rifampicin?

Answer

Atazanavir/ritonavir and darunavir/ritonavir.

72Question

What can subtherapeutic antiretroviral concentrations cause through viral replication?

Answer

Elevated HIV viral load and drug resistance.

73Question

What should clinicians do if a client cannot tolerate doubled LPV/r doses?

Answer

Consult a helpline.

74Question

Why can efavirenz support adherence during rifampicin treatment?

Answer

It has no significant rifampicin interaction and is taken once daily.

75Question

What medication-related burdens can rifampicin treatment create during ART?

Answer

Increased pill burden, reduced ART drug concentrations, and overlapping toxicities.

76Question

What should initial-session assessment check about a patient's medicines?

Answer

Their understanding of the regimen and when each medicine is taken.

77Question

What should counselling advise patients about treatment if they cannot control alcohol use?

Answer

They should continue taking their treatment.

78Question

Which adherence strategies can be discussed during counselling?

Answer

Treatment buddies, alarms, family support, pill counts, calendars, pillboxes, routines, accessible storage, spare work medicines, and modified directly observed therapy.

79Question

What assessments should the initial adherence counselling session explain for HIV, hypertension, and diabetes?

Answer

Further viral load at 3 months for HIV, blood pressure at every visit for the next 3 months for hypertension, and HbA1c at 3 months for diabetes.

80Question

What should be assessed when a mental-health disorder is suspected?

Answer

The main problem, its duration, effects on daily functioning, and clinic capacity to manage it.

81Question

When should a suspected mental-health disorder be referred beyond the clinic?

Answer

When further assessment or treatment is unavailable at the clinic.

82Question

Who recommended the SRQ20 to help identify mental-health disorders?

Answer

The WHO.

83Question

How can dolutegravir and iron supplements be taken together?

Answer

Take them together with food.

84Question

How should lopinavir/ritonavir tablets be taken?

Answer

Swallow them whole.

85Question

What does a child learn during partial HIV disclosure at ages 5–9?

Answer

About illness and why medicine is needed, without being told the illness is HIV.

86Question

What should be assessed before disclosing HIV status fully to an adolescent?

Answer

The adolescent’s cognitive and emotional maturity.

87Question

What should be done to prepare a parent or caregiver before full disclosure to an adolescent?

Answer

Prepare the parent or caregiver for the disclosure.

88Question

What follow-up support should follow full HIV-status disclosure to an adolescent?

Answer

Repeat key information, assess coping and mental health, and address relationships, sexual health, and daily treatment.

89Question

Which email address accepts adverse drug reaction reports?

90Question

Which online portal can be used to submit reports?

Answer

The WHO online e-reporting portal.

91Question

Which smartphone application can be used to submit reports?

Answer

The MedSafety application.

92Question

What BMI range indicates normal weight in adults?

Answer

18.5 to below 25 kg/m².

Test yourself with the quiz

Answer 40 questions on South African HIV ART Guidelines.

1. Which outcome best captures the principal goal of antiretroviral therapy (ART)?

2. A person living with HIV has a high CD4 count and no advanced clinical symptoms; how should their eligibility for ART be assessed?

Take the quiz →

Read the study guide

Go over the full study guide for South African HIV ART Guidelines.

Read the study guide →

Related classes

Make your own flashcards

Upload your class notes and Revizly writes your flashcards in about a minute.

Flashcard maker